Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Selection of a model and estimation of principal pharmacokinetic parameters of dioxadet

Journal Article · · Pharmaceut. Chem. J.; (United States)
OSTI ID:6956227
The authors study the pharmacokinetics of dioxadet, taking into account all the necessary parameters. Dioxadet-/sup 14/C was used, labeled in the ethyleneimine group, which retains radioactivity after the compound has lost its alkylating properties. The authors synthesized it from 2,2-dimethyl-5-hydroxymethyl-(2,4-dichloro-1,3,5-triazin-6-yl)amino-1,3-dioxane and ethyleneimini-2,3-/sup 14/C, obtained from 1,2-dibromoethane-/sup 14/C. The principal pharmacokinetic parameters of dioxadet for eight rats are shown. The synthesis of dioxadet-/sup 14/C, the radiometry of blood samples, and the calculation of the kinetic curve are all discussed.
Research Organization:
N. N. Petrov Scientific-Research Institute of Oncology, Leningrad (USSR)
OSTI ID:
6956227
Journal Information:
Pharmaceut. Chem. J.; (United States), Journal Name: Pharmaceut. Chem. J.; (United States) Vol. 19:10; ISSN PCJOA
Country of Publication:
United States
Language:
English